Public health agencies and non-profits at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
97 public health agencies and non-profits are at IDWeek 2026 — 271 presentations on the program and 12 with a booth in the exhibit hall. Most represented: Centers for Disease Control and Prevention (46 on the program), National Institute of Allergy and Infectious Diseases (7 on the program), New York State Department of Health (6 on the program). As of Oct 16, 2026.
Topic
Top represented
Showing 1–1 of 97 organizations
| Organization | IDWeek 2026 Attendance |
|---|---|
Centers for Disease Control and Prevention Atlanta, GA | |
U.S. public health agency; its emerging and zoonotic infectious diseases center detects, tracks and responds to outbreaks and healthcare-associated infections. | Booth Exhibiting at Booth 311 Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm Talk Tue Oct 20 9:25am–10:15am CDC Core Elements for Outpatient Stewardship: An Updated Framework Antimicrobials, resistance and stewardship Talk Thu Oct 22 8:25am–8:50am Cyclospora 2026: What Have We Learned? Global and public health Session Thu Oct 22 10:30am–11:45am Connecting Across Perspectives: A Shared Path to Disease Elimination Global and public healthTransplant and immunocompromised hostsVaccines Talk Thu Oct 22 11:20am–11:45am Vaccines, Autonomy and Agency Global and public healthTransplant and immunocompromised hostsVaccines Talk Thu Oct 22 11:30am–11:45am Poster Thu Oct 22 12:15pm–1:30pm Candida lipolytica Pseudo-Outbreak Associated with Blood Culture Collection in an Acute Care Hospital Poster Thu Oct 22 12:15pm–1:30pm Demographic and Clinical Characteristics of Patients with Sporotrichosis in Seven Medical Centers, United States Poster Thu Oct 22 12:15pm–1:30pm Genomic insights into the absence of detectable carbapenemase genes in carbapenem-resistant Escherichia coli from the Antibiotic Resistance in Communities and Hospitals (ARCH) Study, India Poster Thu Oct 22 12:15pm–1:30pm Onsite availability of, clinical practices, and barriers related to respiratory virus vaccination reported by long-term care health care providers Poster Thu Oct 22 12:15pm–1:30pm Permitted But Not Chosen: Treatment Choice and Duration for Possible Congenital Syphilis – United States, 2018–2023 Talk Thu Oct 22 1:45pm–2:00pm 60-Day Mortality Among Adults Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus Infection Respiratory infections and COVID-19 Session Thu Oct 22 1:45pm–3:00pm Session Thu Oct 22 1:45pm–3:00pm From Global to Local: The New Face of Threats to U.S. Public Health Global and public health Talk Thu Oct 22 2:10pm–2:35pm Malaria in the United States: Epidemiology and Updated Treatment Guidance for Providers Global and public healthAntimicrobials, resistance and stewardship Talk Thu Oct 22 2:33pm–2:45pm Session Thu Oct 22 3:15pm–4:30pm Pediatric infectious diseases named lecture Global and public healthAntimicrobials, resistance and stewardship Talk Thu Oct 22 3:39pm–3:51pm Talk Thu Oct 22 3:51pm–4:03pm Measles Transmission in Schools – North and South Carolina, 2025–2026 Global and public health Talk Thu Oct 22 4:15pm–4:27pm Outbreak of Carbapenemase–Producing Salmonella Newport Infections Linked to Moringa Capsules Global and public healthAntimicrobials, resistance and stewardship Session Fri Oct 23 8:00am–9:00am Expanding the Diagnostic Toolkit for Viral Hepatitis and Managing Unique Infected Populations HIV, sexually transmitted infections and viral hepatitisDiagnostics and diagnostic stewardship Session Fri Oct 23 8:00am–9:00am Talk Fri Oct 23 8:30am–9:00am Identifying High-Priority Diagnostics and Implementation Considerations in Support of Viral Hepatitis Elimination in the United States HIV, sexually transmitted infections and viral hepatitisDiagnostics and diagnostic stewardship Talk Fri Oct 23 10:50am–11:10am Insights on Ebola from the CDC Global and public health Poster Fri Oct 23 12:15pm–1:30pm Antibiotic Use in a Cohort of U.S. Long-Term Care Facilities Using Electronic Health Record Data, 2022 Poster Fri Oct 23 12:15pm–1:30pm Causes of Death Among Adult People Living with HIV in Tajikistan: Findings from a National HIV Care Cohort, 2010–2023 Poster Fri Oct 23 12:15pm–1:30pm Changes in HIV Antiretroviral Prescribing Patterns During Pregnancies Covered by Public Insurance in the United States, 2010-2023 Poster Fri Oct 23 12:15pm–1:30pm Characteristics and clinical outcomes of immunocompromised adults hospitalized with RSV infection in a multistate surveillance network, RSV-NET, United States, 2022–2026 Poster Fri Oct 23 12:15pm–1:30pm Factors Associated with HIV Integrase Inhibitor Prescription During Pregnancies Covered by Public Insurance in the United States, 2018-2023 Poster Fri Oct 23 12:15pm–1:30pm Rural–Urban Differences in Daily Oral PrEP Prescriptions and Abandonment in the United States, 2022–2024: A National Observational Cohort Study Poster Fri Oct 23 12:15pm–1:30pm Survival After ART Initiation in Tajikistan Across ART Policy Eras: Evidence from a National HIV Cohort, 2010–2023 Poster Fri Oct 23 12:15pm–1:30pm U.S. Outpatient Antibiotic Prescribing, 2011-2024: Changes During Two Decades of Stewardship Session Fri Oct 23 1:45pm–3:00pm Emerging Infections From a One Health Lens Global and public health Talk Fri Oct 23 1:45pm–2:10pm Melioidosis in the Americas: An Evolving Situation Global and public health Session Fri Oct 23 1:45pm–3:00pm “HOT” Topics in Pediatric Infectious Diseases Transplant and immunocompromised hosts Talk Fri Oct 23 2:10pm–2:35pm New World Screwworm Global and public health Talk Fri Oct 23 3:30pm–3:45pm Influenza-associated encephalopathy among children with influenza-associated death – United States, 2025-2026 influenza season Respiratory infections and COVID-19 Talk Fri Oct 23 3:51pm–4:03pm Session Fri Oct 23 4:45pm–6:00pm Lecture in Vaccinology Vaccines Session Sat Oct 24 8:00am–9:00am Connecting Continents: Shared Challenges and Contrasting Customs in Peds ID Global and public health Session Sat Oct 24 8:00am–9:00am Public Health Departments Driving Statewide Antibiotic and Diagnostic Stewardship Global and public healthAntimicrobials, resistance and stewardship Session Sat Oct 24 10:30am–11:45am Enteric Vaccines: Celebrating the Past and Planning the Future Global and public healthVaccines Session Sat Oct 24 10:30am–11:45am Talk Sat Oct 24 10:30am–10:55am Polio Vaccines and Ending Polio Global and public healthVaccines Talk Sat Oct 24 10:42am–10:54am Parental Health Insurance and Use of HIV Prevention Services in Young Adults HIV, sexually transmitted infections and viral hepatitis Talk Sat Oct 24 10:54am–11:06am Trends in Drug Payments for HIV Preexposure Prophylaxis in the United States, 2019–2025: The Generic and Long-Acting Era HIV, sexually transmitted infections and viral hepatitis Poster Sat Oct 24 12:15pm–1:30pm Disease Severity of Human Metapneumovirus Compared with COVID-19, Influenza, and Respiratory Syncytial Virus Among Hospitalized Adults — IVY Network, September 1, 2022 – April 30, 2025 Poster Sat Oct 24 12:15pm–1:30pm Effectiveness of 2025–2026 seasonal influenza vaccines against U.S. pediatric influenza-associated emergency department and urgent care encounters — VISION Network, October 1, 2025–March 4, 2026 Poster Sat Oct 24 12:15pm–1:30pm Effectiveness of 2025–2026 seasonal influenza vaccines against influenza–associated hospitalizations among adults — VISION Network Poster Sat Oct 24 12:15pm–1:30pm Effectiveness of RSV Vaccines in Older Adults in the United States, VISION, 2023-2026 Poster Sat Oct 24 12:15pm–1:30pm Epidemiology and Trends of Invasive Non-toxigenic Corynebacterium diphtheriae in the United States, 2014–2024 Poster Sat Oct 24 12:15pm–1:30pm Incidence of RSV infections among participants in the CASCADIA Prospective Community Cohort Study, Oregon and Washington, United States, November 2023–March 2024 Poster Sat Oct 24 12:15pm–1:30pm Influenza Testing in Urgent Care, Emergency Department, and Inpatient Settings Among Children and Adults – VISION Network, 2023–24 and 2024–25 Seasons. Poster Sat Oct 24 12:15pm–1:30pm Population-Based Surveillance of Antifungal Susceptibility Among Uncommon Candida Species Causing Candidemia, United States, 2017–2025 Poster Sat Oct 24 12:15pm–1:30pm Post-licensure safety monitoring of 20-valent pneumococcal conjugate vaccine (PCV20) in children 2 – 24 months of age in the Vaccine Safety Datalink Poster Sat Oct 24 12:15pm–1:30pm Post-marketing Safety Surveillance of 21-valent Pneumococcal Conjugate Vaccine (PCV21) Among U.S. Adults in the Vaccine Adverse Event Reporting System (VAERS), during June 27, 2024 through December 31, 2025 Poster Sat Oct 24 12:15pm–1:30pm Prior Health Status as the Primary Predictor of Post-COVID Conditions: Evidence from a Bayesian Additive Regression Trees (BART) Analysis Poster Sat Oct 24 12:15pm–1:30pm RSV Immunization Effectiveness among Infants in their First RSV Season in the United States– VISION, October 2025-March 2026 Poster Sat Oct 24 12:15pm–1:30pm Recrudescence and Relapse of Melioidosis in the United States, 2008-2025 Poster Sat Oct 24 12:15pm–1:30pm Safety of live attenuated seasonal influenza vaccine (LAIV) in children aged 2 through 17 years in the Vaccine Adverse Events Reporting System (VAERS), 2018–2023 Poster Sat Oct 24 12:15pm–1:30pm Severity, Infectiousness, and Treatment of Macrolide-Resistant Bordetella pertussis: A Systematic Review Poster Sat Oct 24 12:15pm–1:30pm U.S. Physician Beliefs and Attitudes Towards an Anticipated Lyme Disease Vaccine Session Sat Oct 24 1:45pm–3:00pm Hot Topics in Pulmonary Fungal Infections Respiratory infections and COVID-19 Talk Sat Oct 24 2:10pm–2:35pm Endemic Fungi Causing Community-Acquired Pneumonia Respiratory infections and COVID-19 Session Sat Oct 24 3:15pm–4:30pm So Many Ways to Break an Immune System: Host Dysregulation, Modern Immunosuppressants and the Opportunistic Infections That Slip in Through the Cracks Transplant and immunocompromised hosts |
Instantly find 20 buyers from public health agencies and non-profits
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse IDWeek 2026 by
Organization type
Topic
- Antimicrobials, resistance and stewardship 420
- Vaccines 122
- Diagnostics and diagnostic stewardship 247
- HIV, sexually transmitted infections and viral hepatitis 256
- Infection prevention and healthcare epidemiology 292
- Transplant and immunocompromised hosts 173
- Respiratory infections and COVID-19 163
- Global and public health 211
Exhibit hall
Everyone
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction